Literature DB >> 24938844

Gene expression profiling reveals distinct molecular signatures associated with the rupture of intracranial aneurysm.

Hirofumi Nakaoka1, Atsushi Tajima1, Taku Yoneyama1, Kazuyoshi Hosomichi1, Hidetoshi Kasuya1, Tohru Mizutani1, Ituro Inoue2.   

Abstract

BACKGROUND AND
PURPOSE: The rupture of intracranial aneurysm (IA) causes subarachnoid hemorrhage associated with high morbidity and mortality. We compared gene expression profiles in aneurysmal domes between unruptured IAs and ruptured IAs (RIAs) to elucidate biological mechanisms predisposing to the rupture of IA.
METHODS: We determined gene expression levels of 8 RIAs, 5 unruptured IAs, and 10 superficial temporal arteries with the Agilent microarrays. To explore biological heterogeneity of IAs, we classified the samples into subgroups showing similar gene expression patterns, using clustering methods.
RESULTS: The clustering analysis identified 4 groups: superficial temporal arteries and unruptured IAs were aggregated into their own clusters, whereas RIAs segregated into 2 distinct subgroups (early and late RIAs). Comparing gene expression levels between early RIAs and unruptured IAs, we identified 430 upregulated and 617 downregulated genes in early RIAs. The upregulated genes were associated with inflammatory and immune responses and phagocytosis including S100/calgranulin genes (S100A8, S100A9, and S100A12). The downregulated genes suggest mechanical weakness of aneurysm walls. The expressions of Krüppel-like family of transcription factors (KLF2, KLF12, and KLF15), which were anti-inflammatory regulators, and CDKN2A, which was located on chromosome 9p21 that was the most consistently replicated locus in genome-wide association studies of IA, were also downregulated.
CONCLUSIONS: We demonstrate that gene expression patterns of RIAs were different according to the age of patients. The results suggest that macrophage-mediated inflammation is a key biological pathway for IA rupture. The identified genes can be good candidates for molecular markers of rupture-prone IAs and therapeutic targets.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  gene expression; inflammation; intracranial aneurysm; macrophages; microarray analysis; rupture; subarachnoid hemorrhage

Mesh:

Year:  2014        PMID: 24938844     DOI: 10.1161/STROKEAHA.114.005851

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  37 in total

1.  Chromosome 9p21.3 Variants Are Associated with Cerebral Infarction in Chinese Population.

Authors:  Xuanye Yue; Lili Tian; Xinying Fan; Gelin Xu; Fu-Dong Shi; Xinfeng Liu
Journal:  J Mol Neurosci       Date:  2015-02-11       Impact factor: 3.444

2.  Protective Role of Peroxisome Proliferator-Activated Receptor-γ in the Development of Intracranial Aneurysm Rupture.

Authors:  Kenji Shimada; Hajime Furukawa; Kosuke Wada; Masaaki Korai; Yuan Wei; Yoshiteru Tada; Atsushi Kuwabara; Fumiaki Shikata; Keiko T Kitazato; Shinji Nagahiro; Michael T Lawton; Tomoki Hashimoto
Journal:  Stroke       Date:  2015-04-30       Impact factor: 7.914

3.  Identification of crucial genes in intracranial aneurysm based on weighted gene coexpression network analysis.

Authors:  X Zheng; C Xue; G Luo; Y Hu; W Luo; X Sun
Journal:  Cancer Gene Ther       Date:  2015-02-27       Impact factor: 5.987

4.  Copy number variation analysis in bicuspid aortic valve-related aortopathy identifies TBX20 as a contributing gene.

Authors:  Ilse Luyckx; Ajay A Kumar; Edwin Reyniers; Emily Dekeyser; Kathleen Vanderstraeten; Geert Vandeweyer; Florian Wünnemann; Christoph Preuss; Jean-Michaël Mazzella; Guillaume Goudot; Emmanuel Messas; Juliette Albuisson; Xavier Jeunemaitre; Per Eriksson; Salah A Mohamed; Marlies Kempers; Simone Salemink; Anthonie Duijnhouwer; Gregor Andelfinger; Harry C Dietz; Aline Verstraeten; Lut Van Laer; Bart L Loeys
Journal:  Eur J Hum Genet       Date:  2019-02-28       Impact factor: 4.246

5.  Comparison between smaller ruptured intracranial aneurysm and larger un-ruptured intracranial aneurysm: gene expression profile analysis.

Authors:  Hao Li; Haowen Li; Haiyan Yue; Wen Wang; Lanbing Yu; Yong Cao; Jizong Zhao
Journal:  Neurosurg Rev       Date:  2016-11-14       Impact factor: 3.042

6.  Differential Gene Expression in Coiled versus Flow-Diverter-Treated Aneurysms: RNA Sequencing Analysis in a Rabbit Aneurysm Model.

Authors:  A Rouchaud; C Johnson; E Thielen; D Schroeder; Y-H Ding; D Dai; W Brinjikji; J Cebral; D F Kallmes; R Kadirvel
Journal:  AJNR Am J Neuroradiol       Date:  2015-12-31       Impact factor: 3.825

7.  The pathogenesis shared between abdominal aortic aneurysms and intracranial aneurysms: a microarray analysis.

Authors:  Wen Wang; Hao Li; Zheng Zhao; Haoyuan Wang; Dong Zhang; Yan Zhang; Qing Lan; Jiangfei Wang; Yong Cao; Jizong Zhao
Journal:  Neurosurg Rev       Date:  2017-10-14       Impact factor: 3.042

8.  BAF60a Deficiency in Vascular Smooth Muscle Cells Prevents Abdominal Aortic Aneurysm by Reducing Inflammation and Extracellular Matrix Degradation.

Authors:  Ziyi Chang; Guizhen Zhao; Yang Zhao; Haocheng Lu; Wenhao Xiong; Wenying Liang; Jinjian Sun; Huilun Wang; Tianqing Zhu; Oren Rom; Yanhong Guo; Yanbo Fan; Lin Chang; Bo Yang; Minerva T Garcia-Barrio; Jiandie D Lin; Y Eugene Chen; Jifeng Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-08-13       Impact factor: 8.311

9.  Endovascular Biopsy: In Vivo Cerebral Aneurysm Endothelial Cell Sampling and Gene Expression Analysis.

Authors:  Daniel L Cooke; David B McCoy; Van V Halbach; Steven W Hetts; Matthew R Amans; Christopher F Dowd; Randall T Higashida; Devon Lawson; Jeffrey Nelson; Chih-Yang Wang; Helen Kim; Zena Werb; Charles McCulloch; Tomoki Hashimoto; Hua Su; Zhengda Sun
Journal:  Transl Stroke Res       Date:  2017-09-13       Impact factor: 6.829

10.  Loss of NLRX1 Exacerbates Neural Tissue Damage and NF-κB Signaling following Brain Injury.

Authors:  Michelle H Theus; Thomas Brickler; Armand L Meza; Sheryl Coutermarsh-Ott; Amanda Hazy; Denis Gris; Irving C Allen
Journal:  J Immunol       Date:  2017-10-09       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.